Dr Mark Sheehan has been appointed to the National Research Ethics Advisors Panel. The National Research Ethics Service (NRES) was originally asked by the four UK Health Departments, through the United Kingdom Ethics Committee Authority (UKECA) to establish a central advisory panel. The objective of ... READ MORE
News
Oxford spin-out provides software to monitor vital signs via webcam
A new Oxford spin-out, OxeHealth, spun out from Oxford’s Institute of Biomedical Engineering, will allow a patient’s health to be monitored using a webcam and a software application. The software will detect the patient’s heart rate, respiratory rate and oxygen saturation even in artificial light ... READ MORE
Genetic cause of insulin sensitivity offers diabetes clues
The first single gene cause of increased sensitivity to the hormone insulin has been discovered by a team of Oxford University researchers. The opposite condition – insulin resistance – is a common feature of type 2 diabetes, so finding this cause of insulin sensitivity could offer new ... READ MORE
High speed bench-top sequencing set to change the face of infection control
A study published today in BMJ Open, by researchers from Oxford, Leeds, Brighton and the Health Protection Agency, highlights the use of new bench-top DNA sequencers to quickly and cheaply unravel the entire genetic codes of bacteria causing life-threatening infections. This technology has the ... READ MORE
NHS set to benefit from UK-led technologies
Video games, pioneering gene therapies and new medical devices are set to transform treatments on the NHS, with support from the Department of Health and the Wellcome Trust. The experimental technologies are being developed through the Health Innovation Challenge Fund, which was set up in 2009 to ... READ MORE
Gene therapy trial begins for blindness caused by choroideraemia
Professor Robert MacLaren from the University of Oxford and Professor Miguel Seabra from Imperial College London are undertaking a clinical trial using gene therapy to treat a disease that causes blindness known as choroideraemia. This condition is currently incurable and affects thousands of people ... READ MORE
Trial to investigate new drug combination in lung cancer
Cancer Research UK’s Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tumours and in a subset of patients who have non-small cell lung cancer. This trial will combine two compounds that aim to starve the tumours while simultaneously ... READ MORE
Oxford researchers elected to the Academy of Medical Sciences
Two medical researchers from the Oxford University Hospitals NHS Trust and the University of Oxford have been elected as Fellows of the Academy of Medical Sciences. Professors Tipu Aziz and Rury Holman are among the 46 new Fellows announced by the Academy for their outstanding contributions to ... READ MORE
First electronic retina implanted in the UK
Surgeons in Oxford are the first in the UK to successfully implant an electronic retina into the back of an eye. On 22 March 2012, Chris James became the first patient in the UK to receive this ground-breaking surgery as part of a clinical trial being carried out at John Radcliffe Hospital and ... READ MORE
Professor Russell Foster wins Social Innovator award
Russell Foster (left), Professor of Circadian Neuroscience and Head of the Department of Ophthalmology at the University of Oxford, has been awarded the Social Innovator prize, by the Biotechnology and Biological Sciences Research Council (BBSRC), for his work to revolutionise our understanding of ... READ MORE
- « Previous Page
- 1
- …
- 80
- 81
- 82
- 83
- 84
- …
- 94
- Next Page »